{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T20:07:12Z","timestamp":1784059632200,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673464"],"award-info":[{"award-number":["81673464"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373441"],"award-info":[{"award-number":["81373441"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21372015"],"award-info":[{"award-number":["21372015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Project of Tianjin for New Drug Development","award":["17ZXXYSY00050"],"award-info":[{"award-number":["17ZXXYSY00050"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.lfs.2018.05.032","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T16:27:14Z","timestamp":1526660834000},"page":"35-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Oxyfadichalcone C inhibits melanoma A375 cell proliferation and metastasis via suppressing PI3K\/Akt and MAPK\/ERK pathways"],"prefix":"10.1016","volume":"206","author":[{"given":"Xiaolin","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2018.05.032_bb0005","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1038\/515S109a","article-title":"Melanoma","volume":"515","author":"Owens","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2018.05.032_bb0010","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/515S110a","article-title":"The cancer that rises with the sun","volume":"515","author":"Holmes","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2018.05.032_bb0015","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1038\/onc.2017.76","article-title":"Abl kinase regulation by BRAF\/ERK and cooperation with Akt in melanoma","volume":"36","author":"Jain","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2018.05.032_bb0020","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/onc.2011.361","article-title":"C-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression","volume":"31","author":"Ganguly","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2018.05.032_bb0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejmech.2017.07.034","article-title":"G, Daidone. Recent discoveries of anticancer flavonoids","volume":"142","author":"Raffa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2018.05.032_bb0030","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/md12020636","article-title":"Marine low molecular weight natural products as potential cancer preventive compounds","volume":"12","author":"Stonik","year":"2014","journal-title":"Mar Drugs"},{"key":"10.1016\/j.lfs.2018.05.032_bb0035","article-title":"Clinical outcomes for systemic corticosteroids versus vincristine in treating Kaposiform Hemangioendothelioma and tufted angioma","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lfs.2018.05.032_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40262-017-0563-z","article-title":"Clinical pharmacokinetics of paclitaxel monotherapy: an updated literature review","volume":"57","author":"Stage","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.lfs.2018.05.032_bb0045","series-title":"China Traditional Tibetan Herbal","author":"Luo","year":"1997"},{"key":"10.1016\/j.lfs.2018.05.032_bb0050","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3724\/SP.J.1009.2013.00519","article-title":"Antitumor effects of two extracts from Oxytropis falcata on hepatocellular carcinoma in vitro and in vivo","volume":"11","author":"Yang","year":"2013","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.lfs.2018.05.032_bb0055","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.3892\/ol.2015.3795","article-title":"2\u2032,4\u2032-dihydroxychalcone, a flavonoid isolated from Herba oxytropis, suppresses PC-3 human prostate cancer cell growth by induction of apoptosis","volume":"10","author":"Sheng","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2018.05.032_bb0060","first-page":"1227","article-title":"Influences of Oxytropis falcata on proliferation of SMMC-7721 hepatocarcinoma cells and expression of MMP-2","volume":"36","author":"Yang","year":"2011","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.lfs.2018.05.032_bb0065","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.tiv.2009.05.002","article-title":"Preliminary studies on anti-tumor activity of 2\u2032,4\u2032-dihydroxychalcone isolated from Herba Oxytropis in human gastric cancer MGC-803 cells","volume":"23","author":"Lou","year":"2009","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.lfs.2018.05.032_bb0070","first-page":"42","article-title":"The development of chalcones as promising anticancer agents","volume":"10","author":"Ducki","year":"2007","journal-title":"IDrugs"},{"key":"10.1016\/j.lfs.2018.05.032_bb0075","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1016\/j.tet.2013.11.018","article-title":"Oxyfadichalcones A\u2013C: three chalcone dimers fused through a cyclobutane ring from Tibetan medicine Oxytropis falcata Bunge","volume":"69","author":"Zhang","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.lfs.2018.05.032_bb0080","doi-asserted-by":"crossref","first-page":"19897","DOI":"10.18632\/oncotarget.7658","article-title":"ZSTK474, a specific class I phosphatidylinositol 3-kinase inhibitor, induces G1 arrest and autophagy in human breast cancer MCF-7 cells","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2018.05.032_bb0085","article-title":"Stellettin B induces G1 arrest, apoptosis and autophagy in human non-small cell lung Cancer A549 cells via blocking PI3K\/Akt\/mTOR pathway","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2018.05.032_bb0090","doi-asserted-by":"crossref","first-page":"13577","DOI":"10.3390\/ijms140713577","article-title":"In vitro antimetastatic effect of phosphatidylinositol 3-kinase inhibitor ZSTK474 on prostate cancer PC3 cells","volume":"14","author":"Zhao","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2018.05.032_bb0095","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.05.032_bb0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2184.2003.00266.x","article-title":"The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer","volume":"36","author":"Vermeulen","year":"2003","journal-title":"Cell Prolif."},{"key":"10.1016\/j.lfs.2018.05.032_bb0105","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","article-title":"Integrin signaling","volume":"285","author":"Giancotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.lfs.2018.05.032_bb0110","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1158\/0008-5472.CAN-15-1325","article-title":"Elucidation of the roles of tumor integrin beta1 in the extravasation stage of the metastasis cascade","volume":"76","author":"Chen","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.05.032_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2018.05.032_bb0120","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.2174\/092986709788803222","article-title":"Advances in development of phosphatidylinositol 3-kinase inhibitors","volume":"16","author":"Kong","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lfs.2018.05.032_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2018.05.032_bb0130","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09626","article-title":"Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation","volume":"468","author":"Nazarian","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2018.05.032_bb0135","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.bmcl.2015.09.010","article-title":"Alkaloids from Oxytropis ochrocephala and antiproliferative activity of sophoridine derivatives against cancer cell lines","volume":"26","author":"Tan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2018.05.032_bb0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/acs.jnatprod.7b00736","article-title":"Structurally diverse cytotoxic dimeric chalcones from Oxytropis chiliophylla","volume":"81","author":"Liu","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.lfs.2018.05.032_bb0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jep.2011.04.020","article-title":"Atractylenolide II induces G1 cell-cycle arrest and apoptosis in B16 melanoma cells","volume":"136","author":"Ye","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2018.05.032_bb0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2018.05.032_bb0155","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(00)81238-6","article-title":"Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)","volume":"85","author":"Kiyokawa","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2018.05.032_bb0160","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/35008115","article-title":"AFX-like Forkhead transcription factors medicate cell-cycle regulation by Ras and PKB through p27kip1","volume":"404","author":"Medema","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2018.05.032_bb0165","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/sj.onc.1208352","article-title":"Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity","volume":"24","author":"Yang","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2018.05.032_bb0170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/CMR.0000000000000339","article-title":"Interactions from complementary and alternative medicine in patients with melanoma","volume":"27","author":"Loquai","year":"2017","journal-title":"Melanoma Res."},{"key":"10.1016\/j.lfs.2018.05.032_bb0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2101","article-title":"Genetic determinants of cancer metastasis","volume":"8","author":"Nguyen","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.lfs.2018.05.032_bb0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lfs.2018.05.032_bb0185","first-page":"153","article-title":"Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.lfs.2018.05.032_bb0190","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cellsig.2007.10.018","article-title":"GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy","volume":"20","author":"Takahashi-Yanaga","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2018.05.032_bb0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0959-8049(92)90429-6","article-title":"Identification and interpretation of epidermal growth factor and c-erbB-2 overexpression","volume":"28","author":"Gusterson","year":"1992","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lfs.2018.05.032_bb0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11864-016-0436-y","article-title":"Drug combinations as the new standard for melanoma treatment","volume":"17","author":"Polkowska","year":"2016","journal-title":"Curr. Treat. Options in Oncol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518302935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518302935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T04:47:17Z","timestamp":1604292437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518302935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":40,"alternative-id":["S0024320518302935"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.05.032","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxyfadichalcone C inhibits melanoma A375 cell proliferation and metastasis via suppressing PI3K\/Akt and MAPK\/ERK pathways","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}